Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center

American Journal of Cardiology

Volumn 100, Issue 6, 2007, Pages 949-952

  Bose, Rahul ^a   Gupta, Gaurav ^a   Grayburn, Paul A ^a   Laible, Emily A ^a   Kang, Mi Jung ^a   Choi, James W ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METAL; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; SAFETY; ST SEGMENT ELEVATION; THERAPY EFFECT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; CORONARY RESTENOSIS; CORONARY THROMBOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 34548382993     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.030     Document Type: Article

References (13)

1. Laarman G.J., Suttorp M.J., Dirksen M.T., van Heerebeek L., Kiemeneij F., Slagboom T., van der Wieken L.R., Tijssen J.G.P., Rensing B.J., and Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
2. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M.S., Merkely B., Erglis A., Margheri M., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
3. Menichelli M., Parma A., Pucci E., Fiorilli R., Felice F.D., Nazzaro M., Giulivi A., Alborino D., Azzelino A., and Violini R. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 49 (2007) 1924-1930
4. Park D.W., Park S.W., Park K.H., Lee B.K., Kim Y.H., Lee C.W., Hong M.K., Kim J.J., and Park S.J. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
5. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
6. Hofma S., Ong A., Aoki J., Van Mieghem C., Granillo G., Vaglimigli M., Regar E., de Jaegere P., McFadden E.P., Sianos G., et al. One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart 91 (2005) 1176-1180
7. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J., Turco M., Caputo R., Bergin P., Greenberg J., Popma J., Russell M., and TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
8. Moses J., Leon M., Popma J.J., Fitzgerald P.J., Holmes D., O'Shaughnessy C., Caputo R., Kereiakes D., Williams D., Teirstein P., Jaeger J., Kuntz, Richard E., and SIRIUS Investigators. Sirolumus-eluting stents versus standard stents in patients with stenosis in native coronary artery. N Engl J Med 349 (2003) 1315-1323
9. Park S.J., Shim W.H., Ho D.S., Raizner A.E., Park S.W., Hong M., Lee C.W., Choi D., Jang Y., Lam R., Weissman N.J., and Mintz G.S. A paclictaxel stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
10. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
11. Pasceri V., Granatelli A., Pristipino C., Pelliccia F., Speciale G., Pironi B., Roncella A., and Richichi G. A randomized trial of rapamycin-eluting stent in acute myocardial infarction: preliminary results. Am J Cardiol 92 suppl 1 (2003) 1 (abstr)
12. Regar E., Lemos P., Saia F., Degerteckia M., Tanabe K., Lee C., Arampatzis C., Hoye A., Sianos G., Feyter P., et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol 93 (2004) 1271-1275
13. Ong A., Hoye A., Aoki J., Van Mieghem C., Granillo G., Sonnenschein K., Regar E., McFadden E.P., Sianos G., van der Giessen W.J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953